{"id":345318,"date":"2026-11-12T16:22:58","date_gmt":"2026-11-12T10:52:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/balaxi-pharmaceuticals-q2-results-fy27-pat-1-crore\/"},"modified":"2026-11-12T16:22:58","modified_gmt":"2026-11-12T10:52:58","slug":"balaxi-pharmaceuticals-q2-results-fy27-pat-1-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/balaxi-pharmaceuticals-q2-results-fy27-pat-1-crore\/","title":{"rendered":"Balaxi Pharmaceuticals Q2 Results FY27: PAT Jumps 447.62% to Rs 1.15 Cr, Revenue Rs 81.37 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Balaxi Pharmaceuticals Q2 Results FY27 were declared on 12 November 2026 on a Consolidated basis, covering the July to September 2026 quarter. Revenue stood at Rs 81.37 Cr against Rs 56.18 Cr a year earlier, which is YoY growth of 44.84%. Operating Profit rose 337.61% YoY to Rs 5.12 Cr and net profit rose 447.62% YoY to Rs 1.15 Cr. These quarterly results show revenue, Operating Profit and net profit all moving higher.<\/p>\n<\/div>\n

Balaxi Pharmaceuticals Ltd<\/a> (BALAXI) Q2 Results FY27 announced on 12 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought Consolidated revenue of Rs 81.37 Cr, Operating Profit of Rs 5.12 Cr and PAT of Rs 1.15 Cr. These consolidated results show revenue up 44.84% YoY and net profit up 447.62%. This page tracks Balaxi Pharmaceuticals Q2 Results FY27 line by line.<\/p>\n

This results analysis of Balaxi Pharmaceuticals Q2 Results covers the financial highlights, the business factors behind the quarter, the outlook and the risks. Univest has laid the numbers out so the revenue, Operating Profit and PAT movement is clear at a glance, starting with the Financial Highlights table below.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n